CD8A and neoplasm: Recent research results show that probiotics such as bifidobacteria can reduce the drug resistance of tumor to programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) molecular-targeted drugs, improve its efficacy, and increase the number of CD8+T cells.